Kepos Capital’s Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock VHAQ.U Stock Holding History

Kepos Capital’s Portfolio VHAQ.U Stock Details VHAQ.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-350,000	Closed	-$3.6M	–	457
2020 Q4	$3.6M	Buy	+350,000	New	+$3.59M	0.32%	135

Other funds holding VHAQ.U

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

BCM

Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Kepos Capital's VHAQ.U Position: Q1 2021 in Review

Kepos Capital sold out of Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock (VHAQ.U) in Q1 2021, closing a stake of 350,000 shares — an estimated $3.6M sold.

Kepos Capital first reported a position in VHAQ.U in Q4 2020 and held it in 1 quarter. The position peaked at $3.6M in Q4 2020. 18 funds tracked by Wall St. Rank hold VHAQ.U as of Q1 2021.

Kepos Capital reported no remaining Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock position as of Q1 2021 after selling out during the quarter.
Kepos Capital sold 350,000 Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock shares in Q1 2021, an estimated $3.6M.
Kepos Capital first reported a position in Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock in Q4 2020 and held it in 1 quarter.
Kepos Capital's Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock position peaked at $3.6M in Q4 2020.
18 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock as of Q1 2021.

Based on Kepos Capital's 13F filing for Q1 2021, filed 13 May 2021.